F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

GlaxoSmithKline Intellectual Property (No. 2) Ltd., a subsidiary of GSK Plc, is a company headquartered in Brentford, UK, that provides business support services. The firm was founded in 2012.\nThe company says this about itself: The Company is a member of the GlaxoSmithKline Group (the \"Group\"). The Company's principal activities are the development, enhancement, maintenance, protection and exploitation of intellectual property assets owned by the Company which may include but are not limited to, licensing out intellectual property rights relating to pharmaceutical products to the GlaxoSmithKline Group of companies and carrying out research and development activities.

Nitto Denko Corp. engages in the manufacture and sale of adhesives, optical films, semiconductors, electronic devices, and consumer products. It operates through the following segments: Industrial Tape, Optronics, Human Life, and Others. The Industrial Tape segment deals with the manufacture and sale of sealing, protective, process, and automotive materials. The Optronics segment offers optical films, printed circuits, and high-precision substrates. The Human Life segment handles the manufacturing services for nucleic acids, nucleic acid synthesis materials, and medical-related materials. The Others segment includes new businesses. The company was founded on October 25, 1918 and is headquartered in Osaka, Japan.

Universal Stabilization Technologies, Inc. is an American private company located in San Diego, CA, that provides business support services.\nThe company says this about itself: UST is a privately held San Diego-based biopharmaceutical R&D company focused on the formulation of long-term ambient temperature stable biopharmaceuticals. UST offers VitriLife® research and development services for its customers as well as formulation of oral, respiratory, transdermal, sublingual, and other delivery devices for AT stable vaccines and other biopharmaceuticals.

ABEC, Inc. is an American private company located in Bethlehem, PA, with operations in Ireland, that provides engineering, services processes, process consulting, equipment upgrades, maintenance and other services for pharmaceutical companies. It was founded in 1974 by Jack Wilson. Scott Pickering is currently the CEO of the firm.\nThe company says this about itself: Since 1974, ABEC has been a global leader in delivering engineered solutions and services for manufacturing in the biotech industry. A majority of the world's pharmaceutical and biotech companies are ABEC customers; with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed, and serviced by ABEC. ABEC's unique value is based on long experience, complete in-house capabilities, a customized, flexible approach, and long-term credibility. Whether adding capacity or improving existing facilities, ABEC's turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity.

Innoville Intelligent Technology is a provider of biological production solutions. They are mainly involved in systems for batch research and industrial-scale production, testing, and storage of the entire production line. They also provides batch research of biopharmaceuticals and industrial scale production, testing, and storage.

PowderJect Research Ltd., a subsidiary of Pfizer Inc., is a company headquartered in the United Kingdom. The firm operates as a non-trading company.

​​​​​​​Vaxiion Therapeutics is a clinical stage biopharmaceutical company developing a proprietary biopharmaceutical drug delivery system based on its targeted recombinant bacterial minicell (rBMC) technology for use in cancer. rBMCs are small, chromosomeless (i.e., non-living and non-infectious), spherical bacterial particles engineered to encapsulate, target, and deliver a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides, and imaging agents) directly to cancer cells.

Part of Lonza Group AG, Lonza Ltd. is a company headquartered in Basel, Switzerland, that supplies chemicals for pharmacy industry.

Integrated Biosystems, Inc. supplied patented technology and equipment for controlled freezing, thawing and frozen storage of biopharmaceutical products. The company was founded by Lee Leonard in 1996 and was headquartered in Benicia, CA.

Part of Biosynth Ltd., Celares GmbH is a company headquartered in Berlin, Germany. The firm develops and manufactures conjugate vaccines and bio conjugate drugs. It was founded in 2003 by Frank Leenders, Guenther Paetz and Ralf Kraehmer. Ralf Kraehmer is currently the CEO of the company. Biosynth Ltd. acquired Celares GmbH on July 11, 2023.\nThe company says this about itself: celares GmbH is focused on development and manufacturing of polymer-based drug delivery excipients and bioconjugate drugs. Established in 2003 and based in Berlin, Germany, celares is a leader in the field of bioconjugation/half-life extension by chemical modification and the synthesis of specialty polymers for drug delivery. celares provides high-quality customised services, including feasibility studies, up-scaling and process development, as well as the development and validation of required analytical methods. Furthermore, celares is offering GMP production of bioconjugates and functionalized polymers used as excipients in drug formulation

Speximo develops an emulsifier based on starch grain from quinoa. Applications are in the cosmetics, pharmaceutical and food industries. With Speximo's technology you can produce creams and ointments with a completely green profile. Speximo AB is a research based company providing competence and a patented emulsifying technology for oil-water based products. The lab continuously solves formulation problems and explores new applications. Since 2013 the headquarter and R&D facilities are placed at Medicon Village in Lund, Sweden. Speximo offers green and sustainable stabilization of emulsions. The technology provides opportunities ranging from stabilization of surfactant free systems to encapsulation of high value ingredients. Speximo was founded by the world leading experts in starch Pickering emulsions and has close collaboration with researchers from Lund University and Malmö University exploring the fundamental properties of the technology and its use in cosmetic, pharmaceutical, and food applications.

Mitsubishi Gas Chemical Co., Inc. engages in the manufacture and sale of organic and inorganic chemicals, petroleum-derived chemicals, and its related products. It operates through the following segments: Natural Gas Chemicals, Aromatic Chemicals, Functional Chemicals, Specialized Functional Materials, and Others. The Natural Gas Chemicals segment produces and sells methanol, ammonia, amines, methacrylate, polyol, enzyme, functional food materials, and crude oil. The Aromatic Chemicals segment engages in the manufacture and sale of xylene isomers and xylene derivatives. The Functional Chemicals segment deals with the production and sale of industrial inorganic chemicals, electronic chemicals, and engineering plastics. The Specialized Functional Materials segment manufactures and sells printed circuit boards and oxygen absorbers. The Others segment covers the real estate business. The company was founded on January 15, 1918 and is headquartered in Tokyo, Japan.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Part of Ouro Fino Sa��de Animal Participa����es SA, Regenera Medicina Veterinaria Avancada Ltda. is a company headquartered in Brazil. The firm develops therapeutic products involving stem cells for animals. Ouro Fino Sa��de Animal Ltda. acquired Regenera Medicina Veterinaria Avancada Ltda. on March 31, 2022 for $3.64 million.

W. L. Gore & Associates has made its name by creating innovative, technology-driven solutions, from medical devices that treat aneurysms to high-performance GORE‑TEX® fabrics. A privately held company with annual sales of more than $3 billion, Gore is committed to perpetuating its 50-plus year tradition of product innovation. Gore focuses its efforts in four main areas: electronics, fabrics, industrial and medical products. The company’s electronic products division develops and manufactures high-performance copper and optical signal transmission products. Gore’s fabrics provide protection from the elements and enable wearers to remain comfortable across a broad range of activities and conditions. The products made by Gore’s industrial division meet diverse contamination control and processing challenges throughout industry. Implants from the medical division provide creative healing solutions to complex medical problems. Today, Gore employs more than 10,000 employees, called associates, with manufacturing facilities in the United States, Germany, the United Kingdom, Japan and China, and sales offices around the world.

Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.